Avila Therapeutics' Series B Round

Avila Therapeutics raised a round of funding on July 21, 2009.

Avila Therapeutics is developing new medicines that achieve 'protein silencing' based on the proprietary Avilomics platform. Per the company, these medicines, called covalent drugs, strongly and resil…

Articles about Avila Therapeutics' Series B Round: